OSF Ventures Joins Early Funding for First FDA-Cleared Wireless Seizure Detection Sensor

PEORIA, Ill., March 10, 2022 /PRNewswire/ — OSF companies joins six other investors in a Series A, $12.5 million round of funding for a wireless, wearable EEG (brain wave monitor) to detect seizures, even those that are not convulsive and without obvious signs. Catalyst Health Ventures (CHV) and Genoa Ventures co-led the oversubscribed advance financing with participation from Dexcom, Inc. (DXCM), Wavemaker 360 and existing investors MedMountain Ventures and Salt Lake City Angels.



The prevalence of neurodegenerative disorders increases as the US population ages. The World Health Organization says that one in 10 people will experience a seizure in their lifetime and that there are approximately 3.4 million people in United States diagnosed with epilepsy. However, two-thirds of Americans do not have easy access to EEG monitoring, and most emergency departments lack the capacity to screen for neuroemergencies.


The Epitel one-inch square wireless sensor features a proprietary adhesive that easily and discreetly sticks to the patient’s scalp, just below the hairline. Two sensors can be worn on the forehead while the other two can be located behind one ear for early detection when a doctor suspects cognitive impairment. Currently, Epitel’s disposable wireless EEG sensors and remote access software known as REMI® are cleared by the FDA for use in hospital settings, but the company plans to seek clearance for use in various patient care settings.


Bedside nurses instead of EEG technicians can easily attach Epitel’s miniature sensors in minutes, and brainwave activity can be recorded to see changes over time. The results are transmitted from the cloud to the REMI patient monitoring platform, easily accessible on a tablet.


“This technology really helps break down barriers to access because not only will it reduce EEG initiation time, but the sensors and monitoring software give rural hospitals that don’t have EEG resources the ability to screen patients with suspected seizure activity, instead of proceeding immediately requiring transfer to a larger tertiary hospital.”
Liridon Rrushajdirector of OSF Venture Investments.


“OSF HealthCare has many rural hospitals within its 15-hospital system, and the ease of use enables early detection of neurological issues so physicians can proactively address care options before the worst symptoms arise. “, adds Rrushaj.


Wireless technology prevents obstructions in recordings from electrographic capture activity or antenna noise that comes with tethered wires that are part of currently available wired systems. Epitel’s sensors can provide real-time tracking of adult and pediatric patients suspected of having neurological complications, potentially accelerating diagnoses and treatment in community hospitals.


“Epitel’s system is truly an innovative solution to a widespread problem – EEG machines and skilled technicians are in short supply, with an ever-increasing demand,” says Dr. Deepak Nairdirector of ambulatory and virtual neurology services for OSF HealthCare Illinois Neurological Institute and neurological hospitalist at OSF HealthCare Saint Francis Medical Center in Peoria. “The Epitel team has developed a simple and powerful tool that allows us to provide remote EEG monitoring, which speeds up diagnosis and treatment. This approach to diagnostic medicine is exactly the transformative thinking that will help decentralize the delivery of advanced neurological care.”


OSF Ventures will work with Epitel to further support its value proposition as the company works to commercialize its REMI platform.


Chairman and CEO of Epitel Mark LehmkuhlePhD, emphasizes, “We look forward to additional clinical contributions from OSF HealthCare specialists and we are honored to have the support of OSF Ventures as part of a strong investment syndicate that will help us advance our platform and our product portfolio. We are driven by our belief that rapid diagnosis and treatment enabled by our technology can lead to more effective treatment plans, better outcomes and improved quality of life for people with epilepsy and other neurological disorders.”


For additional resources for this press release, please visit the OSF press room.


OSF companies specializes in business optimization, partnering financially and operationally with companies that improve patient outcomes and reduce costs for healthcare systems. OSF Ventures is a division of OSF HealthCare. More than osfventures.org.


OSF Healthcare is an integrated healthcare system owned and operated by the Sisters of the Third Order of St. Francis, headquartered in Peoria, Ill.. OSF HealthCare employs nearly 24,000 mission partners at 150 sites, including 15 hospitals – 10 acute care, five critical access – with 2,089 licensed beds and two nursing colleges across Illinois and Michigan. The OSF HealthCare Physician Network employs more than 1,500 primary, specialty and advanced practice providers. OSF HealthCare, through OSF Home Care Services, operates an extensive network of home health care and palliative care services. He also owns Pointcore, Inc., comprised of healthcare-related businesses, and OSF HealthCare Foundation, the organization’s philanthropic arm. More than osfhealthcare.org.


Epitel, Inc. builds an EEG monitoring platform to provide accessible, affordable and reliable diagnostics. The company provides critical EEG access in emergency, critical care, urban and rural environments, as well as systems to monitor patients at home through its proprietary wireless sensor. Epitel unlocks EEG monitoring for patients, caregivers, and providers anytime, anywhere. Learn more about epitel.com.


contacts: Colleen Reynolds | Media Relations Coordinator, OSF Healthcare | cell: (309) 825-7255



Quote Show original content to download multimedia:https://www.prnewswire.com/news-releases/osf-ventures-joins-early-financing-for-first-fda-cleared-wireless-seizure-detection-sensor-301500486.html


SOURCE OSF Ventures

Lillian L. Pena